| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| LEMONIS MARCUS | EXECUTIVE CHAIRMAN & CEO, Director | 433 ASCENSION WAY, 3RD FLOOR, MURRAY | /s/ Christina Wheeler, Attorney-in-Fact | 12 Mar 2026 | 0001136478 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBBY | Common Stock | Award | +166,666 | +37% | 622,817 | 10 Mar 2026 | Direct | F1 | ||
| transaction | BBBY | Common Stock | Tax liability | -59,813 | -9.6% | $4.91* | 563,004 | 10 Mar 2026 | Direct | ||
| transaction | BBBY | Common Stock | Award | +141,432 | +25% | 704,436 | 10 Mar 2026 | Direct | F2, F3 | ||
| transaction | BBBY | Common Stock | Tax liability | -34,680 | -4.9% | $4.91* | 669,756 | 10 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBBY | Restricted Stock Units | Options Exercise | -166,666 | -33% | $0.000000* | 333,334 | 10 Mar 2026 | Common Stock | 166,666 | Direct | F1 | ||
| transaction | BBBY | Performance Shares | Options Exercise | -141,432 | -33% | $0.000000* | 282,868 | 10 Mar 2026 | Common Stock | 141,432 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest or have vested in three equal installments at the close of business on March 10, 2026, March 10, 2027 and March 10, 2028. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. |
| F2 | Each performance share represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. On March 10, 2025 the reporting person was granted an award of performance shares, which are scheduled to vest in three equal installments at the close of business on March 10, 2026, March 10, 2027, and March 10, 2028, subject to and upon the satisfaction of certain performance criteria. On February 4, 2026, the compensation committee of the Issuer's board of directors determined that a total of 424,300 performance shares were earned based on performance relative to the performance criteria for fiscal year 2025. Accordingly, one-third of the earned performance shares (or 141,432 performance shares) vested on March 10, 2026. |
| F3 | (Continued from footnote 2) The remaining earned performance shares will vest based on continued service through the applicable vesting date specified above. Amounts shown reflect performance shares from the subject grant beneficially owned following the transaction reported herein. |